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ABSTRACT 
Objective: Maternal depressive symptoms during pregnancy are associated with increased risk of 
psychiatric problems in children. More precise understanding of the timing of the symptoms during 
pregnancy and their independence from other prenatal and postnatal factors in predicting child 
psychopathology risk is needed. We examined whether maternal depressive symptoms during pregnancy 
predict child psychiatric problems, whether these associations are trimester- or gestational-week-specific 
and/or independent of pregnancy disorders, and whether maternal depressive symptoms after pregnancy 
mediate or add to the prenatal effects.   
Method: The study sample comprised 2,296 women and their children born in Finland between 2006-2010, 
participating in the prospective pregnancy cohort study Prediction and Prevention of Preeclampsia and 
Intrauterine Growth Restriction (PREDO) and followed up from 1.9 to 5.9 years of age. The women 
completed the Center for Epidemiologic Studies Depression Scale biweekly between gestational 
weeks+days 12+0/13+6 and 38+0/39+6 or delivery. In the follow-up, they completed the Beck Depression 
Inventory-II and Child Behavior Checklist 1½-5.  
Results: Maternal depressive symptoms during pregnancy predicted significantly higher internalizing (0.28 
SD unit per SD unit increase [95% CI=0.24-0.32]), externalizing (0.26[0.23-0.30]) and total problems 
(0.31[0.27-0.35]) in children. These associations were non-specific to gestational week and hence pregnancy 
trimester, independent of pregnancy disorders, and independent of, though partially mediated by maternal 
depressive symptoms after pregnancy. Psychiatric problems were greatest in children whose mothers 
reported clinically significant depressive symptoms across pregnancy trimesters and during and after 
pregnancy. 
Conclusion:  Maternal depressive symptoms during pregnancy predict increased psychiatric problems in 
young children. Preventive interventions from early pregnancy onwards may benefit offspring mental health. 
Key words: antenatal; depression; childhood mental health; psychiatric symptoms; prospective study.  
INTRODUCTION 
Maternal depressive symptoms affect a large proportion of pregnancies, with 7.4%-20% of women 
experiencing clinically significant levels of depressive symptoms at different stages of pregnancy.1-2 These 
symptoms may alter the intrauterine environment, expose the fetus to unnecessarily high levels of maternal 
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glucocorticoids3-5 and pro-inflammatory cytokines,6-7 and “program” an adverse offspring phenotype, 
thereby explaining why maternal depressive symptoms during pregnancy predict an increased risk of 
psychiatric problems in the offspring.8-19 
Yet, it still remains unclear whether maternal depressive symptoms during pregnancy are an 
independent risk factor for child psychiatric problems.8-19 In the Avon Longitudinal Study of Parents and 
Children (ALSPAC), which is one of the two largest studies that have examined the consequences of 
maternal depressive symptoms during pregnancy on the offspring, maternal depressive symptoms measured 
at gestational weeks 18 or 32 predicted higher risks of attention problems in the offspring in early 
childhood,17 and emotional and behavioral problems in pre-puberty.12 In the Generation R study, the other of 
the two largest studies, maternal depressive symptoms at gestational week 20 were associated with higher 
risk of offspring attention problems17 and internalizing and externalizing problems18 in early childhood. In 
ALSPAC, the associations remained significant after adjusting for maternal depressive symptoms at the time 
of rating the child’s psychiatric problems.12,17 However, in Generation R, the associations were no longer 
significant,17-18 challenging the assumption that the effects of maternal depression would be due to an 
adverse intrauterine environment. 
While differences in sample characteristics and assessment tools may at least partially explain the 
contradictory findings, these and some other smaller-scale previous studies were limited to assessing 
maternal depressive symptoms “during the past seven days or last two weeks’’ only once or twice during 
pregnancy.8-19 Hence, it remains unknown whether some developmental periods during pregnancy are more 
vulnerable than others to the effects of maternal depressive symptoms, and if feeling depressed throughout 
pregnancy is more harmful for the offspring than feeling depressed only for a week or two at one or two 
arbitrary timepoints. However, since depressive symptoms show high stability,8,12 disentangling gestation-
week or trimester-specific effects of maternal depressive symptoms during pregnancy may prove difficult. It 
also remains unclear whether maternal depressive symptoms concurrent to rating the child’s problems add to 
rather than account for, or mediate the effects of prenatal environmental adversities.  
Accordingly, we examined whether depressive symptoms measured biweekly from gestational week 
12 onwards up to 14 times during pregnancy in a large cohort of pregnant Finnish women predict the levels 
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of psychiatric problems in their 1.9–5.9-year-old children, and whether maternal depressive symptoms at the 
time of rating the child’s problems add to, account for, or mediate any effects of maternal depressive 
symptoms during pregnancy. Another novel contribution of this study was to account for possible 
confounding by common pregnancy disorders: pre-pregnancy obesity, gestational diabetes, and 
hypertension-spectrum pregnancy disorders. According to previous studies, these disorders co-occur with 
depressive symptoms20-21 and are associated with offspring psychiatric problems.22-24  
METHOD 
Participants 
The Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study 
enrolled 4,785 pregnant women, of whom 4,777 (8 miscarriages or stillbirths) gave birth to a singleton live-
born child between 2006 and 2010.4-5,25 The women were recruited to the study when they visited antenatal 
clinics at one of the ten study hospitals in Southern and Eastern Finland for their first ultrasound screening 
between 12+0 and 13+6 weeks+days of gestation. Of these women, 3,402 (71.2% of those with live-born 
offspring) filled in the biweekly depressive symptoms questionnaire during pregnancy. 
In 2011-2012, 4,586 women and their children of the original sample were invited for a follow-up 
(three children had died after birth and before the follow-up, 33 did not have data in the Finnish nation-wide 
medical birth register, 55 women had declined participation in a follow-up, and for 100 women, addresses 
were not traceable). Of these, 2,667 women and children (58.2% of those invited) participated. 
Of the 4,586 mothers invited to the follow-up, 3,279 had data on depressive symptoms during 
pregnancy, and 2,296 had both pregnancy and follow-up data available. The current study sample comprises 
these 2,296 women and their 1.9- to 5.9-year-old children (1,161 boys, 1,135 girls; 70.0% of those with data 
on depressive symptoms during pregnancy and invited to the follow-up). 
In comparison to the non-participants in the original sample (n=2,489), the current study participants 
were older at delivery (mean difference=0.7 years, p<.001), had more often tertiary education (62.8% vs. 
54.7%, p<.001), were less often obese (body mass index [BMI]≥30 kg/m2) before pregnancy (12.3% vs. 
15.9%, p<.001), and less often multiparous (58.1% vs. 64.4%, p<.001), smoked less often throughout 
pregnancy (2.8% vs. 7.1%, p<.001), and more often had a daughter (49.4% vs. 46.2%, p=.03). All 
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participating mothers signed informed consent forms. The PREDO study protocol was approved by ethical 
committees of the Helsinki and Uusimaa Hospital District.  
Maternal Depressive Symptoms 
The women completed the Center for Epidemiologic Studies Depression Scale (CES-D)26 biweekly 
up to 14 times throughout pregnancy starting from 12+0/13+6 gestation weeks+days until 38+0/39+6 
gestation weeks+days or delivery. The 20 CES-D questions were rated on a scale from none of the time (0) 
to all the time (3). Higher scores indicate more depressive symptoms during the past week and a sum-score 
of ≥16 indicates risk for clinical depression.26-27  
In the follow-up, the women completed the Beck Depression Inventory-II (BDI-II), which comprises 
21 items, each containing four statements (scored from 0 to 3) reflecting increasing severity of depressive 
symptoms during the past two weeks.28 A sum-score of ≥14 indicates at least mild depressive 
symptomatology.28-29 
Both depression scales have good psychometric properties,26-31 and the CES-D has been used 
extensively and validated also in pregnant populations.30-31 In our sample, the CES-D (Cronbach`s α=.88 to 
.92 in the 14 biweekly measurement points) and the BDI-II (α=.91) showed high internal consistency.   
Child Psychiatric Problems 
Child Behavior Checklist for ages 1½-5 (CBCL/1½-5), filled in by the child`s mother, comprises 99 
problem items rated on a scale of not true (0) to very true or often true (2).32 The CBCL/1½-5 yields scores 
for three main scales (internalizing, externalizing, and total problems), seven syndrome scales (emotionally 
reactive, anxious/depressed, somatic complaints, withdrawn, sleep problems, attention problems, and 
aggressive behavior) and five DSM-oriented scales (affective, anxiety, pervasive developmental, attention 
deficit/hyperactivity, and oppositional defiant problems).34 A t-score of ≥60 on the main and of ≥65 on the 
syndrome and DSM-oriented scales indicates at least borderline clinically significant problems.32 The 
CBCL/1½-5 has good test-retest reliability, internal consistency, and criterion validity.32-33 
Pregnancy Disorders 
Data on maternal pregnancy disorders were extracted from medical reports independently verified by 
a clinical jury and/or from the Finnish Medical Birth Register.25 These included pre-pregnancy obesity 
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(BMI≥30 kg/m2 vs. BMI<30 kg/m2), hypertension spectrum pregnancy disorders (preeclampsia, gestational 
hypertension; yes/no), and gestational diabetes (yes/no).21,25,34-35 
Covariates 
These included maternal age at delivery (years), smoking during pregnancy (did not smoke/quit 
during first trimester/smoked throughout pregnancy), parity (primiparous/multiparous) chronic hypertension 
(yes/no), type 1 diabetes (yes/no), child’s sex, gestational length (weeks), birth weight (g), and family 
structure at childbirth (cohabitation/marriage vs. single parent), with data extracted from medical reports 
and/or Medical Birth Register; maternal history of physician-diagnosed depression before pregnancy 
(yes/no), psychotropic medication use during pregnancy (antidepressants, other [barbiturates, sedatives, 
antipsychotics] vs. no), alcohol use during pregnancy (yes/no), and education level (basic/secondary vs. 
tertiary), each self-reported in a questionnaire given to the mothers at 12+0-13+6 weeks+days of gestation; 
and child’s age at follow-up (years), which was reported in conjunction with filling in the CBCL 
questionnaire.    
Data Analysis 
We examined the course of depressive symptoms during pregnancy with latent profile analysis and 
Pearson correlation analysis. 
Next, we inspected the crude unadjusted mean differences of maternal depressive symptoms across 
the 14 measurement points during pregnancy according to child internalizing, externalizing, and total 
problems scores above and below the borderline clinical cutoff, and calculated Cohen’s d’s for effect sizes.  
We then used linear regression analyses to test associations between maternal depressive symptoms 
during pregnancy and child internalizing, externalizing, and total problems. We examined gestation week- 
specific effects and also calculated a trimester-weighted mean value of depressive symptoms across 
pregnancy (mean of the only value from first pregnancy trimester and the mean values of second trimester 
and third trimester) and square-root transformed the values to normalize the distributions. Since scores in the 
CBCL/1½-5 syndrome and DSM-oriented scales below 50 were truncated into 50 according to the manual,32 
resulting in strongly skewed distributions and a “floor effect,” Tobit regressions were used in the analyses of 
these scales. To facilitate interpretation, both the predictor and outcome variables were standardized to the 
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mean of 0 and SD of 1. 
The associations of maternal depressive symptoms during pregnancy with child psychiatric problems 
were examined in four different linear or Tobit regression models. Model 1 was adjusted for child’s age and 
sex. Model 2 was adjusted for the covariates in model 1 and family structure, maternal age at childbirth, 
parity, education level, type 1 diabetes, chronic hypertension, history of depression before pregnancy, 
antidepressant and other psychotrophic medication use, alcohol use and smoking during pregnancy, 
gestation length, and infant’s birth weight adjusted for sex and gestation length. Model 3 was adjusted for 
the model 2 covariates and prepregnancy obesity, gestational diabetes, and hypertension-spectrum 
pregnancy disorders. Model 4 was adjusted for the model 3 covariates and maternal depressive symptoms 
after pregnancy at the time of rating the child’s psychiatric problems. 
With linear and/or Tobit regressions, we also tested whether child psychiatric problem scores 
increased according to the number of pregnancy trimesters (0,1,2,3) during which the mean maternal CES-D 
score was above the clinical cut-off of >16; whether child psychiatric problem scores differed between the 
groups of mothers identified by a latent profile analysis based on their depressive symptoms scores across 
pregnancy; whether maternal pregnancy disorders accounted for the effects of maternal depressive 
symptoms during pregnancy (analyses were adjusted for the pregnancy disorders and re-run separately in 
mothers with and without pregnancy disorders); and whether maternal depressive symptoms after pregnancy 
accounted for (postpartum depressive symptoms were added as a covariate into the 4th regression models), 
mediated (mediation analyses were performed with the bootstrapping method using 5000 bootstrapping re-
samples with bias-corrected confidence intervals), or added to the effects of maternal depressive symptoms 
during pregnancy (interaction term of depressive symptoms during pregnancy x after pregnancy was entered 
into the regression equation followed by the main effects). 
In additional analyses, we studied age-specific associations by re-running the analyses separately 
among children who were 1.9-3.9 years and 4.0-5.9 years at follow-up. We also re-ran the analyses 
separately among children born to mothers with and without depression diagnoses before pregnancy. 
Finally, in a subsample from whom we had paternal CES-D depressive symptoms data available when the 
children were 6 months old (n=1,237), we examined if paternal depressive symptoms confounded any 
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effects of maternal depressive symptoms. 
RESULTS 
Table 1 shows the characteristics of the study sample. The CES-D scores were highly intercorrelated 
across pregnancy (Pearson r`s between .44 and .80, p-values<.001). Latent profile analysis identified a 
solution with three groups as the most optimal (in comparison to solutions with fewer and larger number of 
groups) to depict depressive symptoms throughout pregnancy (Akaike Information Criterion = 184565.50, 
sample-size-adjusted Bayesian Information Criterion=184714.10, Vuong-Lo-Mendell-Rubin LRT and Lo-
Mendell-Rubin Adjusted Likelihood Ratio Test p-values =.02). In all three groups, which differed from each 
other in their level of depressive symptoms, depressive symptoms showed high stability. One trajectory was 
described by consistently high, one by consistently moderate, and one by consistently low depressive 
symptom scores (Figure S1, available online). The CES-D mean score during pregnancy also correlated 
significantly with the BDI-II score in the follow-up (r=.45, p<.001), and child internalizing, externalizing, 
and total problems were highly inter-correlated (r`s from .62 to .90, p-values<.001). Maternal pregnancy 
disorders were not associated with child psychiatric problems, but maternal history of depression before 
pregnancy was associated with significantly higher child internalizing, externalizing, and total psychiatric 
problems. Table S1 (available online) shows these and the associations of the other covariates with child 
psychiatric problems.  
Maternal Depressive Symptoms During Pregnancy and Child Psychiatric Problems 
Figure 1 (Panel A) shows that at each biweekly measurement point during pregnancy, mothers 
whose children scored above the borderline clinical cutoffs in internalizing, externalizing, and total 
problems had significantly higher depressive symptom scores than mothers whose children scored below the 
cutoffs; these group differences were of medium effect size (Cohen’s d’s varying from 0.36 to 0.52).  
Figure 1 (Panel B) and Tables S2, S3 (available online) show that the effects of maternal depressive 
symptoms across pregnancy and at each biweekly assessment on child internalizing, externalizing, and total 
problems were significant when adjusted for covariates in linear regression models 1-2. Table S2 (available 
online) shows that higher maternal mean depressive symptoms during pregnancy also predicted significantly 
higher CBCL syndrome- and DSM-oriented problem scores of the child across Tobit regression models 1-2.  
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As shown in Figure 2 (Panel A), child internalizing, externalizing, and total psychiatric problem 
scores increased linearly according to the number of pregnancy trimesters during which the mother reported 
mean depressive symptoms above the clinical cutoff of ≥16. We also compared the psychiatric problems of 
children of mothers with consistently high, moderate, and low depressive symptoms during pregnancy, as 
identified by the latent profile analysis. Figure 2 (Panel B) shows that child internalizing, externalizing, and 
total psychiatric problem scores were the highest in children born to mothers who had consistently high 
depressive symptoms during pregnancy. Adjustments for covariates in models 1-4 had no effects on these 
associations (Figure 2).  
Pregnancy Disorders, Maternal Depressive Symptoms During Pregnancy and Child Psychiatric 
Problems 
When we made further adjustments for maternal pre-pregnancy obesity, hypertension-spectrum 
pregnancy disorders, and gestational diabetes, all the associations between maternal depressive symptoms 
during pregnancy and child psychiatric problems remained significant (Figures 1 [Panel B, model 3] and 2 
and Tables S2-S3, model 3, available online). We re-ran the analyses in groups who were and were not 
exposed to maternal pregnancy disorders, and in both groups, the associations were significant (Figure S2, 
available online).  
The Moderating and Partially Mediating Effects of Maternal Depressive Symptoms After Pregnancy 
Figures 1 (Panel B, model 4) and 2 and Tables S2-S3 (model 4, available online) show that, although 
maternal depressive symptoms after pregnancy, concurrently to rating the child psychiatric problems, were 
significantly associated with higher internalizing, externalizing, and total problems as well as syndrome 
scale- and DSM-oriented problems of the child (unstandardized regression coefficients in 4th regression 
models =0.22 to 0.47, p-values<.001), maternal depressive symptoms across pregnancy and at each 
biweekly assessment remained significant predictors of all types of child psychiatric problems after 
adjustment for maternal depressive symptoms after pregnancy; although in effect size these associations 
were somewhat attenuated. Mediation analyses demonstrated that while maternal depressive symptoms 
during pregnancy had a direct effect on child internalizing, externalizing, and total problems, maternal 
depressive symptoms after pregnancy partially mediated the prenatal effects (Figure 3). 
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In addition to partially mediating the prenatal effects, maternal depressive symptoms after pregnancy 
added to the effects of depressive symptoms during pregnancy on internalizing (p-value for interaction 
between maternal depressive symptoms during x after pregnancy=.02) and total problems (p for 
interaction=.049). Figure 4 shows that child internalizing and total problems scores were greatest if the 
mother reported both prenatal depressive symptoms above the clinical cutoff of ≥16 and depressive 
symptoms after pregnancy above the clinical cutoff of ≥14, compared to the scores of children whose 
mothers had clinically significant symptomatology either during or after pregnancy or who had both scores 
below the clinical cutoffs.    
The Age-Specificity of the Effects of Maternal Depressive Symptoms During Pregnancy and the 
Moderating Role by Maternal History of Depression Before Pregnancy 
Table S4 (available online) shows that higher maternal depressive symptoms during pregnancy 
independently predicted significantly higher child internalizing, externalizing, and total problems both 
among children who were 1.9-3.9 and 4.0-5.9 years old. 
  Higher maternal depressive symptoms during pregnancy predicted higher psychiatric problems both 
among children born to mothers with and without a diagnosis of depression before pregnancy (Figure S3, 
available online). However, the associations with internalizing problems were inconsistent across models 1-
4 among children whose mothers had been diagnosed with depression before pregnancy. 
No Confounding by Paternal Depressive Symptoms in Child’s Infancy 
At child age 6 months, 1,237 fathers assessed their depressive symptoms (mean=7.4, SD=6.0: r=.15 
and r=.11 with maternal depressive symptoms during and after pregnancy, respectively, p-values<.001). 
Linear regression analyses in this subsample showed that maternal depressive symptoms during pregnancy 
predicted significantly higher child internalizing, externalizing, and total problems independently of model 4 
covariates and paternal depressive symptoms (unstandardized regression coefficients=0.17, =0.15, and 
=0.19, respectively, p-values<.001).  
DISCUSSION 
Our prospective study shows that higher maternal depressive symptoms during pregnancy predicted 
significantly higher levels of child psychiatric problems in early childhood across all the domains captured 
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by the CBCL.32 While maternal depressive symptoms after pregnancy at the time of evaluating the child’s 
psychiatric problems were also associated with significantly higher child psychiatric problems, the prenatal 
effects were not accounted for by the after-pregnancy effects. Instead, higher maternal depressive symptoms 
after pregnancy only partially mediated the prenatal effects. Additional analyses showed that they also added 
to child psychiatric problems, such that children of mothers with clinically significant depressive symptoms 
both during and after pregnancy had the highest internalizing and total problems scores. All the associations 
were independent of a number of important covariates, including common pregnancy disorders and paternal 
depressive symptoms when the children were 6 months old. 
That the effects of maternal depressive symptoms during pregnancy on child psychiatric problems 
were independent of depressive symptoms after pregnancy correspond well with findings from ALSPAC12,17 
but contradict findings from Generation R,17-18 studies of comparable sample size to ours. In ethnic 
background, our sample is more similar to the ALSPAC, which comprises almost entirely Caucasian 
offspring, than it is to the multiethnic Generation R. This offers one possible explanation why our findings 
differ from the findings in Generation R. Most importantly, however, our study captured depressive 
symptomatology throughout the entire pregnancy unprecedented by these two and any other previous 
studies.8-19 The multiple, repeated, biweekly measurements in our study indeed reduced measurement error 
and increased the reliability and internal validity of our findings. Hence, our study offers the most 
comprehensive view reported so far on the effects of maternal depressive symptoms during pregnancy on 
child psychiatric problems.  
The repeated measurements allowed us also to capture any gestational-week-specific effects. This is 
relevant since maternal physiology changes during pregnancy and pregnant women become physiologically 
more stress resistant as pregnancy advances.36 Yet, we found that maternal depressive symptoms showed 
high stability across the biweekly measurements. Therefore, it was not surprising to discover that the effects 
of depressive symptoms on child psychiatric problems were non-specific to gestation week and hence 
pregnancy trimester. Regardless of detecting these non-specific effects, the level of child psychiatric 
problems increased according to the number of pregnancy trimesters during which the mother reported 
clinically significant depressive symptoms. This highlights the importance of evaluating depressive 
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symptoms multiple times during pregnancy. An alternative explanation for these findings is that they reflect 
both the chronicity and the severity of depressive symptoms throughout pregnancy. While our study does 
not provide the means to disentangle chronicity from severity, the results of our latent profile analysis 
showing that child psychiatric problems were the highest in the group of mothers who had consistently high 
depressive symptoms during pregnancy favors this interpretation.  
Although the effects of maternal depressive symptoms during pregnancy were clearly independent of 
symptoms reported after pregnancy, maternal depressive symptoms after pregnancy still played a role in two 
important ways: symptoms after pregnancy both partially mediated and added to the prenatal effects. These 
findings emphasize that both the pre- and the postnatal periods should be targets of preventive interventions 
and reinforce the assessment of maternal depressive symptoms in routine antenatal and postpartum health 
care.2   
The effects of maternal depressive symptoms during pregnancy on child psychiatric problems were 
also independent of maternal physician-diagnosed depression before pregnancy, although the effects were 
more pronounced and evident on all types of child psychiatric problems in the group who did not report 
physician-diagnosed depression before pregnancy. Among those with history of depression, intrauterine 
effects did not systematically add to the effects on internalizing symptoms but did predict externalizing and 
total problems. These somewhat contrasting findings may well reflect the much larger group of mothers with 
no physician-diagnosed depression before pregnancy available for analysis in our study.  
Fetal overexposure to maternal glucocorticoids and inflammatory cytokines may underlie the 
prenatal programming effects. For instance, previous studies have demonstrated that higher maternal 
depressive symptoms during pregnancy are associated with higher mRNA levels of the glucocorticoid 
receptor (GR) and mineralocorticoid receptor genes in the placenta4 and that higher placental GR mediate 
the effects of maternal depressive symptoms on infant regulatory behavior.5 Other studies have pointed to 
associations of maternal depression during pregnancy with epigenetic modifications of the GR gene in the 
placenta and fetal cord blood DNA3 and found cross-sectional associations between altered GR gene 
methylation in DNA from peripheral blood leukocytes with adolescent internalizing problems.37 Also, higher 
maternal prenatal pro-inflammatory marker levels have been associated with both maternal depressive 
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symptoms during pregnancy6-7 and offspring autism risk.38 However, the sociobiological pathways 
underlying the development of maternal depression and child psychopathology are beyond the scope of this 
study. Further studies unraveling these underlying mechanisms and studies focusing on the underlying 
genetic and epigenetic mechanisms are warranted. 
Strengths of our study include a sizable, homogenous sample, prospective design, repeated 
measurements of depressive symptoms during pregnancy and concurrently when rating child’s psychiatric 
problems, and data on multiple important covariates. The homogeneity of the sample is, however, also a 
limitation, as is the follow-up sample attrition that was not independent of maternal characteristics. Half of 
the original cohort was lost to follow-up, which limits the external validity of our findings. Furthermore, we 
had a single informant on child problems. Using multiple informants would have given a more 
comprehensive picture of the associations. However, maternal depressive symptoms during pregnancy have 
previously been shown to predict child psychiatric problems, whether these were assessed by parents, 
teachers, self-reports, or clinical interviews.8-19 Another limitation is that we only had data on paternal 
depressive symptoms for a subsample. Furthermore, while we had data on paternal depressive symptoms 
when the child was 6 months old, we did not have paternal depressive symptoms available when the mother 
was pregnant. Although adjustment for paternal depressive symptoms at 6 months did not influence our 
findings, further studies are needed to clarify the contribution of paternal depressive symptoms to maternal 
intrauterine effects. While paternal depression is an important covariate implicating familial confounding, 
adjustment for paternal depressive symptoms did not influence our findings.  Although we made 
adjustments for family structure, we lacked data on relationship stress that may contribute to the association 
between maternal depression and child psychopathology.8 Moreover, generalizations from our findings 
cannot be made to psychiatric disorders since we measured psychiatric problems dimensionally. Since the 
mothers rated their depressive symptoms after pregnancy concurrently to child problems, shared method 
variance may have inflated the effect size estimates of the associations found, as mothers with depression 
may perceive more problems in their children. Also the mediation effects observed do not, strictly defined, 
evidence mediation, since child well-being may also influence maternal mental state. However, reverse 
causation cannot explain the prenatal effects. 
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In conclusion, our prospective study showed that higher maternal depressive symptoms during 
pregnancy predict significantly higher psychiatric problems in children. These associations were non-
specific to pregnancy trimester and gestational week and independent of, though partially mediated by, 
maternal depressive symptoms after pregnancy. Psychiatric problem levels were greatest in children whose 
mothers reported clinically significant depressive symptoms across pregnancy trimesters and both during 
and after pregnancy. Ongoing studies will unravel the biological and psychosocial mechanisms and enable 
the design of preventive, targeted, family-based interventions, which, according to our findings, should 
focus both on the mother and her baby and start from early pregnancy onwards.  
Clinical Guidance 
●Our findings show that maternal depressive symptoms should be assessed as a part of routine antenatal and 
postpartum care due to their adverse consequences for both the mothers and their children.  
●Maternal depressive symptoms during pregnancy predict increased psychiatric problems in children 
independently of cardiometabolic pregnancy disorders and maternal depressive symptoms postpartum. 
●Maternal depressive symptoms show high stability throughout pregnancy and remain stable from 
pregnancy to postpartum and have additive effects on child psychiatric problems. 
●Early interventions may prevent psychiatric problems both in the mother and the child. 
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Table 1. Characteristics of the Sample 
 Data Available(N) Mean(SD)/N(%)
Maternal characteristics   
  Age at delivery (years) 2296 31.9 (4.6) 
  Education, tertiary 2296 1443 (62.8 %) 
  Parity, primiparous 2291 961 (41.9 %) 
  Family structure, single 2193 35 (1.6 %)  
  Pre-pregnancy BMI (kg/m2) 2296 24.3 (4.8) 
   Obese (BMI≥30)  283 (12.3 %) 
  History of depression before pregnancy, Yes 2186 214 (9.8%) 
  Antidepressants medication use during pregnancy, Yes 1952 49 (2.5 %) 
  Other psychotropic medication use during pregnancy, Yes 1952 14 (0.7 %) 
  Gestational hypertension-spectrum disorder, Yes 2296 179 (7.8 %) 
  Chronic hypertension, Yes 2296 83 (3.6 %) 
  Gestational diabetes, Yes  2296 235 (10.2 %) 
  Type 1 diabetes, Yes 2296 11 (0.5 %) 
  Alcohol use during pregnancy, Yes 2275 374 (16.4 %) 
  Smoking during pregnancy, No 2296 2156 (93.9 %) 
  Quit during the first trimester  75 (3.3 %) 
  Smoked throughout pregnancy  65 (2.8 %) 
 Depressive symptoms during pregnancy   
  Trimester-weighted mean of center for epidemiologic studies depression  
    Scale sum-scores 
2296 11.4 (6.4) 
  Trimester-weighted mean of center for epidemiologic studies depression  
   Scale sum-scores≥16 
2296 489 (21.3 %) 
 Depressive symptoms after pregnancy   
  BDI-II sum-score 2269 6.4 (6.3) 
  BDI-II sum-score≥14, yes 2269 274 (12.1 %) 
Child characteristics   
  Sex, boys 2296 1161 (50.6 %) 
  Gestational age (weeks) 2296 39.9 (1.6) 
  Birth weight (grams) 2296 3520.9 (510.9) 
  Age at follow-up (year) 2296 3.5 (0.7) 
Child Behavior Checklist/1½-5 Psychiatric Problems   
  Main scales   
   Internalizing problems 2296 45.8 (9.4) 
    Scored above the borderline clinical cutoff, Yes 2296 197 (8.6 %) 
   Externalizing problems 2296 47.5 (9.1) 
    Scored above the borderline clinical cutoff, Yes 2296 225 (9.8 %) 
   Total problems 2296 46.4 (9.2) 
    Scored above the borderline clinical cutoff, Yes 2296 183 (8.0 %) 
Syndrome scales   
   Emotionally reactive 2296 52.9 (4.8) 
   Anxious/depressed 2296 51.1 (2.9) 
   Somatic complaints 2296 54.0 (5.9) 
   Withdrawn 2296 53.0 (4.5) 
   Sleep problems 2296 54.1 (5.5) 
   Attention problems 2296 51.9 (3.5) 
   Aggressive behaviour 2296 53.1 (5.2) 
DSM-oriented scales   
   Affective problems 2296 53.6 (5.0) 
   Anxiety problems 2296 52.1 (4.2) 
   Pervasive developmental problems 2296 53.3 (5.3) 
   ADHD problems 2296 52.1 (3.8) 
   Oppositional defiant problems 2296 53.7 (5.5) 
 
Note: ADHD = attention-deficit/hyperactivity disorder; BDI = Beck Depression Inventory; BMI = body mass index; ODD = 
oppositional defiant disorder.
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FIGURE TITLES AND LEGENDS 
Figure 1. Maternal depressive symptoms during pregnancy and psychiatric problems in children. 
Note: Panel A: Crude unadjusted means and 95% CIs (error bars) of maternal biweekly depressive 
symptoms during pregnancy according to child’s Internalizing, Externalizing, and Total Problems 
scores above (solid lines) and below (dashed lines) the borderline clinical cutoffs. Panel B: 
Unstandardized regression coefficients (B) and 95% CIs of linear regression analyses on the 
associations between trimester-weighted mean of maternal depressive symptoms during pregnancy 
and child internalizing, externalizing, and total problems in linear regression models 1-4. SD = 
standard deviation. 
Figure 2. Additive effects of maternal trimester-specific depressive symptoms during pregnancy on 
child psychiatric problems. Note: Panel A: Estimated marginal means and 95% CIs of child 
internalizing, externalizing, and total problems according to the number of pregnancy trimesters 
during which the mother had mean depressive symptoms above the clinical cutoff of ≥16 are shown. 
Estimated marginal means are adjusted for child’s age and sex; p-values refer to linear trends in 
regression models 1-4. Panel B: Estimated marginal means and 95% CIs of child internalizing, 
externalizing, and total problems in three groups identified by latent profile analysis on maternal 
depressive symptoms across pregnancy. Estimated marginal means are adjusted for child’s age and 
sex; p values refer to linear trends in regression models 1-4.  
Figure 3. Maternal depressive symptoms during pregnancy partially act via symptoms after 
pregnancy on child psychiatric problems. Note: Mediation analyses showing that maternal 
depressive symptoms during pregnancy partially act via maternal depressive symptoms after 
pregnancy to impact on child internalizing (Panel A), externalizing (Panel B), and total (Panel C) 
problems are shown. The numbers represent unstandardized regression coefficients (B), 95% CIs, 
and p values. The estimates are adjusted for child’s age and sex; p values refer to effects in 
regression models 1-3. 
Figure 4. Additive effects of maternal depressive symptoms during and after pregnancy on child 
internalizing and total problems. Note: Estimated marginal means and 95% CIs of child internalizing 
(Panel A) and total (Panel B) problems according to mean maternal depressive symptoms during 
pregnancy above and below the clinical cutoff of ≥16 on the Center for Epidemiologic Studies 
Depression Scale (CES-D) and after pregnancy above and below the clinical cutoff of ≥14 on the Beck 
Depression Inventory-II (BDI-II) are shown. The estimated marginal means are adjusted for child’s 
age and sex: p values refer to linear trends in regression models 1-3. 
Figure S1. Latent profile analysis on the course of maternal depressive symptoms during pregnancy. 
Note: The figure shows the mean levels of depressive symptoms at different gestational weeks in 
three latent profile analysis-derived groups of mothers who show consistently low, moderate, and 
high levels of depressive symptoms throughout pregnancy. CES-D = Center for Epidemiologic Studies 
Depression Scale. 
Figure S2. Maternal depressive symptoms during pregnancy and child psychiatric problems in groups 
with and without pregnancy disorders. Note: Maternal depressive symptoms during pregnancy and 
child psychiatric problems among those with maternal pregnancy disorders (pre-pregnancy obesity, 
gestational hypertensive disorders, and gestational diabetes) (Panel A: n=541) and among those 
without (Panel B: n=1,755) are shown. Unstandardized regression coefficients (B) and their 95% CI of 
linear regression models adjusted for the covariates in models 1-3. The third models refer here to 
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regression models adjusted further for maternal depressive symptoms at the time of rating the 
child’s problems.  
Figure S3. Maternal depressive symptoms during pregnancy and child psychiatric problems in groups 
with and without maternal diagnosis of depression before pregnancy. Note: Maternal depressive 
symptoms during pregnancy and child psychiatric problems among those with maternal self-
reported history of physician-diagnosed depression before pregnancy (Panel A: n=214) and among 
those without (Panel B: n=1,982) are shown. Unstandardized regression coefficients (B) and their 
95% CI of linear regression models adjusted for the covariates in models 1-4. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
20 
 
 
Table S1. The Associations of the Covariates With Child Psychiatric Problems  
 CBCL Scale 
Internalizing Problemsa Externalizing Problemsa Total Problemsa 
Maternal Characteristics r /Mean Differenceb p r /Mean Differenceb p r /Mean Differenceb p 
Age at delivery -.09 <.001 -.11 <.001 -.12 <.001 
Education: Primary or secondary vs. tertiary .05 .31 .11 .01 .08 .05 
Parity: Primiparous vs. other .40 <.001 .21 <.001 .34 <.001 
Family structure: single vs. cohabiting  .17 .30 .04 .83 .08 .63 
History of depression before pregnancy (yes vs. no) .24 .002 .20 .01 .26 <.001 
Antidepressant use during pregnancy (yes vs. no) .02 .88 .26 .07 .21 .14 
Other psychotropic medication use during pregnancy (yes vs. no) .37 .17 .43 .11 .44 .10 
Alcohol Use During Pregnancy (yes vs. no) .01 .91 .06 .29 .01 .83 
Quit smoking during first trimester vs. no smoking during 
pregnancy 
.18 .13 .23 .04 .22 .06 
Smoked throughout pregnancy vs. no smoking during pregnancy .31 .01 .49 <.001 .44 .001 
Smoked throughout pregnancy vs. quit during first trimester .13 .43 .25 .13 .21 .20 
Pre-pregnancy obesity (yes/no) -.03 .63 .09 .18 .04 .56 
Gestational hypertension-spectrum disorder (yes/no) -.00 .95 -.00 .96 -.00 .99 
Chronic hypertension (yes/no) -.00 >.99 -.08 .50 -.04 .74 
Gestational diabetes (yes/no) -.02 .80 -.02 .76 -.01 .87 
Type 1 Diabetes (yes/no) .17 .56 .39 .20 .27 .37 
Child Characteristics 
Sex (Boy vs. Girl) -.03 .48 .26 <.001 .15 <.001 
Gestational age -.03 .13 -.03 .21 -.03 .16 
Birth weight adjusted for gestational age and sex -.08 <.001 -.05 .03 -.06 .005 
Age at follow-up .07 .002 -.08 <.001 -.04 .03 
Paternal depressive symptoms in child’s infancy .14 <.001 .08 .003 .14 <.001 
Note: CBCL = Child Behavior Checklist. 
a Child psychiatric problem scores are expressed in standard deviation units 
b r refers to Pearson correlation coefficients of continuous covariates with child psychiatric problems; mean difference refers to mean group differences between the groups of the 
categorical covariates in child psychiatric problems in independent samples t-test analyses. 
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Table S2. The Associations Between Trimester-Weighted Mean of Maternal Depressive Symptoms During Pregnancy and Child Psychiatric Problems  
CBCL Scale Model 1 (n=2,296)a  Model 2 (n=2,296)a  Model 3 (n=2,296)a  Model 4(n=2,269)a,b  
Main Scales B(95% CI)c p B(95% CI)c p B(95% CI)c  p B(95% CI)c  p 
Internalizing Problems 0.28(0.24-0.32) <.001 0.28(0.24-0.32) <.001 0.29(0.25-0.33) <.001 0.18(0.13-0.22) <.001 
Externalizing Problems 0.26(0.23-0.30) <.001 0.26(0.22-0.30) <.001 0.26(0.22-0.30) <.001 0.16(0.12-0.20) <.001 
Total Problems 0.31(0.27-0.35) <.001 0.31(0.27-0.35) <.001 0.31(0.27-0.35) <.001 0.20(0.15-0.24) <.001 
Syndrome Scales         
Emotionally Reactive 0.41(0.33-0.49) <.001 0.41(0.33-0.48) <.001 0.42(0.34-0.49) <.001 0.25(0.17-0.34) <.001 
Anxious/Depressed 0.56(0.44-0.68) <.001 0.56(0.44-0.68) <.001 0.56(0.44-0.68) <.001 0.35(0.23-0.48) <.001 
Somatic Complaints 0.37(0.29-0.45) <.001 0.38(0.30-0.47) <.001 0.39(0.30-0.47) <.001 0.26(0.17-0.35) <.001 
Withdrawn 0.29(0.23-0.36) <.001 0.33(0.26-0.39) <.001 0.33(0.26-0.39) <.001 0.20(0.13-0.27) <.001 
Sleep Problems 0.30(0.24-0.36) <.001 0.30(0.24-0.36) <.001 0.30(0.24-0.36) <.001 0.20(0.13-0.27) <.001 
Attention Problems 0.35(0.28-0.43) <.001 0.35(0.28-0.43) <.001 0.35(0.27-0.43) <.001 0.22(0.13-0.30) <.001 
Aggressive Behaviour 0.46(0.38-0.54) <.001 0.45(0.37-0.53) <.001 0.45(0.37-0.53) <.001 0.28(0.19-0.37) <.001 
DSM-Oriented Scales         
Affective Problems 0.30(0.25-0.35) <.001 0.30(0.25-0.36) <.001 0.31(0.25-0.36) <.001 0.20(0.14-0.25) <.001 
Anxiety Problems 0.45(0.36-0.55) <.001 0.44(0.34-0.54) <.001 0.44(0.34-0.54) <.001 0.29(0.19-0.40) <.001 
Pervasive Developmental Problems 0.32(0.26-0.39) <.001 0.34(0.27-0.41) <.001 0.34(0.28-0.41) <.001 0.21(0.14-0.29) <.001 
ADHD Problems 0.39(0.31-0.47) <.001 0.40(0.32-0.48) <.001 0.40(0.32-0.48) <.001 0.25(0.16-0.33) <.001 
Oppositional Defiant Problems 0.31(0.25-0.37) <.001 0.31(0.24-0.37) <.001 0.31(0.25-0.37) <.001 0.18(0.12-0.25) <.001 
Note: ADHD = attention-deficit/hyperactivity disorder; CBCL = Child Behavior Checklist. 
a Model 1 is adjusted for the age and sex of the child; Model 2 further for family structure, maternal age at delivery, parity, education level, type 1 diabetes, chronic hypertension, history of depression 
before pregnancy, antidepressant and other psychotropic medication use, alcohol use and smoking during pregnancy, gestation length and child’s birth weight adjusted for gestation length and sex; 
Model 3 further for pre-pregnancy obesity, hypertension-spectrum pregnancy disorders and gestational diabetes: and Model 4 for maternal depressive symptoms after pregnancy at the time of rating the 
child’s psychiatric problems.  
b The fourth analytic model includes 2269 participants since 27 mothers had missing data on depressive symptoms after pregnancy and were excluded from these analyses. In contrast, participants with 
missing values on categorical covariates were dummy-coded into separate categories in the regression analysis.  
c Bs and 95% CIs for main scales are unstandardized regression coefficients and their 95% CIs are from linear regression analyses: Bs and 95% CIs for syndrome and DSM-Oriented Scales are 
unstandardized regression coefficients and 95 % confidence intervals from tobit regression analyses. Both the independent and dependent variables are expressed in standard deviation units. 
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Table S3. Maternal Biweekly Depressive Symptoms During Pregnancy and Child Psychiatric Problems 
Maternal Depressive Symptoms at Internalizing Problems Externalizing Problems Total Problems 
12-13 weeks of gestation (n=2193) B (95% CI) B (95% CI) B (95% CI) 
Model 1 0.22 (0.17-0.26) 0.22 (0.18-0.27) 0.25 (0.21-0.29) 
Model 2 0.22 (0.18-0.26) 0.22 (0.18-0.26) 0.25 (0.21-0.29) 
Model 3 0.22 (0.18-0.26) 0.22 (0.18-0.26) 0.25 (0.21-0.29) 
Model 4 0.12 (0.07-0.16) 0.13 (0.08-0.17) 0.14 (0.10-0.18) 
14-15 weeks of gestation (n=2142) 
Model 1 0.22 (0.18-0.26) 0.22 (0.17-0.26) 0.25 (0.21-0.29) 
Model 2 0.24 (0.19-0.28) 0.21 (0.16-0.25) 0.25 (0.21-0.29) 
Model 3 0.22 (0.18-0.26) 0.20 (0.16-0.25) 0.25 (0.21-0.29) 
Model 4 0.12 (0.08-0.17) 0.12 (0.07-0.16) 0.14 (0.10-0.18) 
16-17 weeks of gestation (n=2110) 
Model 1 0.23 (0.19-0.27) 0.21 (0.17-0.25) 0.26 (0.21-0.30) 
Model 2 0.23 (0.19-0.28) 0.21 (0.17-0.25) 0.25 (0.21-0.29) 
Model 3 0.24 (0.20-0.28) 0.21 (0.16-0.25) 0.25 (0.21-0.29) 
Model 4 0.14 (0.10-0.18) 0.12 (0.08-0.16) 0.15 (0.11-0.19) 
18-19 weeks of gestation (n=2133) 
Model 1 0.21 (0.17-0.25) 0.20 (0.16-0.24) 0.24 (0.20-0.28) 
Model 2 0.20 (0.16-0.24) 0.19 (0.15-0.23) 0.23 (0.19-0.27) 
Model 3 0.20 (0.16-0.25) 0.19 (0.15-0.23) 0.23 (0.19-0.27) 
Model 4 0.12 (0.07-0.16) 0.11 (0.07-0.15) 0.13 (0.09-0.17) 
20-21 weeks of gestation (n=2111) 
Model 1 0.23 (0.19-0.27) 0.22 (0.17-0.26) 0.25 (0.21-0.30) 
Model 2 0.23 (0.19-0.27) 0.21 (0.16-0.25) 0.25 (0.21-0.29) 
Model 3 0.23 (0.19-0.27) 0.20 (0.16-0.25) 0.25 (0.21-0.29) 
Model 4 0.13 (0.09-0.18) 0.12 (0.07-0.16) 0.15 (0.11-0.19) 
22-23 weeks of gestation (n=2081) 
Model 1 0.22 (0.17-0.26) 0.22 (0.18-0.26) 0.25 (0.20-0.29) 
Model 2 0.21 (0.17-0.25) 0.21 (0.17-0.25) 0.24 (0.20-0.28) 
Model 3 0.21 (0.17-0.26) 0.21 (0.16-0.25) 0.24 (0.20-0.28) 
Model 4 0.12 (0.07-0.16) 0.12 (0.08-0.16) 0.14 (0.09-0.18) 
24-25 weeks of gestation (n=2055) 
Model 1 0.23 (0.19-0.27) 0.21 (0.17-0.25) 0.25 (0.20-0.29) 
Model 2 0.22 (0.18-0.26) 0.20 (0.15-0.24) 0.23 (0.19-0.27) 
Model 3 0.22 (0.18-0.27) 0.19 (0.15-0.24) 0.23 (0.19-0.28) 
Model 4 0.13 (0.09-0.18) 0.11 (0.07-0.16) 0.14 (0.09-0.18) 
26-27 weeks of gestation (n=2076) 
Model 1 0.23 (0.18-0.27) 0.22 (0.18-0.26) 0.25 (0.21-0.29) 
Model 2 0.22 (0.18-0.26) 0.21 (0.17-0.25) 0.24 (0.20-0.28) 
Model 3 0.22 (0.18-0.26) 0.21 (0.17-0.25) 0.24 (0.20-0.28) 
Model 4 0.12 (0.08-0.17) 0.12 (0.08-0.17) 0.14 (0.10-0.18) 
28-29 weeks of gestation (n=2055) 
Model 1 0.26 (0.22-0.30) 0.22 (0.18-0.26) 0.27 (0.23-0.31) 
Model 2 0.26 (0.21-0.30) 0.21 (0.17-0.25) 0.26 (0.22-0.31) 
Model 3 0.26 (0.22-0.30) 0.21 (0.17-0.25) 0.26 (0.22-0.31) 
Model 4 0.16 (0.12-0.21) 0.12 (0.08-0.16) 0.16 (0.12-0.20) 
30-31 weeks of gestation (n=2056) 
Model 1 0.25 (0.20-0.29) 0.22 (0.18-0.26) 0.27 (0.23-0.31) 
Model 2 0.25 (0.21-0.29) 0.22 (0.18-0.26) 0.27 (0.23-0.31) 
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Model 3 0.25 (0.21-0.30) 0.22 (0.18-0.26) 0.27 (0.23-0.31) 
Model 4 0.16 (0.11-0.20) 0.13 (0.08-0.17) 0.16 (0.12-0.21) 
32-33 weeks of gestation (n=2061) 
Model 1 0.26 (0.22-0.30) 0.23 (0.19-0.27) 0.28 (0.24-0.32) 
Model 2 0.27 (0.23-0.31) 0.23 (0.19-0.27) 0.28 (0.24-0.32) 
Model 3 0.27 (0.23-0.31) 0.23 (0.19-0.27) 0.28 (0.24-0.32) 
Model 4 0.18 (0.13-0.22) 0.14 (0.09-0.18) 0.18 (0.13-0.22) 
34-35 weeks of gestation (n=2020) 
Model 1 0.25 (0.20-0.29) 0.22 (0.18-0.26) 0.27 (0.22-0.31) 
Model 2 0.25 (0.21-0.29) 0.21 (0.17-0.25) 0.26 (0.22-0.30) 
Model 3 0.25 (0.21-0.30) 0.21 (0.17-0.25) 0.26 (0.22-0.31) 
Model 4 0.16 (0.12-0.21) 0.12 (0.08-0.17) 0.16 (0.12-0.21) 
36-37 weeks of gestation (n=1957) 
Model 1 0.23 (0.19-0.27) 0.20 (0.16-0.24) 0.25 (0.21-0.29) 
Model 2 0.24 (0.19-0.28) 0.20 (0.16-0.24) 0.25 (0.21-0.30) 
Model 3 0.24 (0.20-0.28) 0.20 (0.16-0.24) 0.26 (0.21-0.30) 
Model 4 0.16 (0.11-0.20) 0.12 (0.08-0.17) 0.17 (0.12-0.21) 
38-39 weeks of gestation (n=1669) 
Model 1 0.22 (0.18-0.27) 0.19 (0.14-0.23) 0.24 (0.19-0.28) 
Model 2 0.23 (0.19-0.28) 0.18 (0.14-0.23) 0.24 (0.19-0.28) 
Model 3 0.23 (0.19-0.28) 0.19 (0.14-0.23) 0.24 (0.20-0.29) 
Model 4 0.15 (0.10-0.20) 0.11 (0.06-0.16) 0.15 (0.10-0.20) 
Note: Model 1 is adjusted for child’s age and sex; Model 2 further for family structure, maternal age at delivery, parity, 
education, type 1 diabetes, chronic hypertension, history of depression before pregnancy, antidepressant and other 
psychotropic medication use, alcohol use and smoking during pregnancy, gestation length and child’s birth weight adjusted 
for gestation length and sex: Model 3 further for pre-pregnancy obesity, hypertension-spectrum pregnancy disorders, and 
gestational diabetes, and Model 4 also for maternal depressive symptoms after pregnancy at the time of rating child’s 
psychiatric problems. Bs and 95% CIs are unstandardized regression coefficients and their 95% CIs are from linear regression 
models. All independent and dependent variables are expressed in standard deviation units. All the associations are highly 
statistically significant (p<.001). 
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Table S4. Age-Specific Associations Between Trimester-Weighted Mean of Maternal Depressive Symptoms During Pregnancy and Child Psychiatric Problems 
Age of the child Model 1 Model 2  Model 3  Model 4 
1.9-3.9 years  (n=1,564) B(95 % CI) p B(95 % CI) P B(95 % CI) p B(95 % CI) p 
Internalizing Problems 0.29(0.25-0.34) <.001 0.30(0.25-0.34) <.001 0.30(0.25-0.34) <.001 0.19(0.14-0.24) <.001 
Externalizing Problems 0.27(0.22-0.32) <.001 0.27(0.22-0.31) <.001 0.26(0.22-0.31) <.001 0.17(0.12-0.22) <.001 
Total Problems 0.32(0.28-0.37) <.001 0.32(0.27-0.37) <.001 0.32(0.27-0.37) <.001 0.21(0.16-0.26) <.001 
4-5.9 years  (n=732) 
Internalizing Problems 0.25(0.18-0.32) <.001 0.26(0.18-0.33) <.001 0.26(0.19-0.34) <.001 0.15(0.07-0.24) <.001 
Externalizing Problems 0.25(0.18-0.32) <.001 0.25(0.18-0.32) <.001 0.25(0.18-0.32) <.001 0.15(0.06-0.23) <.001 
Total Problems 0.29(0.22-0.36) <.001 0.29(0.22-0.36) <.001 0.29(0.22-0.36) <.001 0.17(0.09-0.25) <.001 
Note: Model 1 is adjusted for the age and sex of the child; Model 2 further for family structure, maternal age at delivery, parity, education level, type 1 diabetes, chronic hypertension, 
history of depression before pregnancy, antidepressant and other psychotropic medication use, alcohol use and smoking during pregnancy, gestation length and child’s birth weight adjusted 
for gestation length and sex; Model 3 further for pre-pregnancy obesity, hypertension-spectrum pregnancy disorders and gestational diabetes; and Model 4 for maternal depressive 
symptoms after pregnancy at the time of rating the child’s psychiatric problems. Bs and 95% CIs for main scales are unstandardized regression coefficients, and their 95% CIs are from 
linear regression analyses. Both the independent and dependent variables are expressed in standard deviation units. 
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